Evaluation of Antibacterial Activity of Bryopsis pennata and Chaetomorpha antennina against  Multidrug Resistant Morganella morganii and  Salmonella species Isolated from Healthy  Individuals by Beukes, D. et al.
_____________________________________________________________________________________________________ 
 
*Corresponding author: E-mail: sade.agbaje-daniels@crawforduniversity.edu.ng, teeshade@yahoo.com; 
 
 
Journal of Pharmaceutical Research International 
 
18(4): 1-7, 2017; Article no.JPRI.35924 
ISSN: 2456-9119 
(Past name: British Journal of Pharmaceutical Research, Past ISSN: 2231-2919, 
NLM ID: 101631759) 
 
 
Evaluation of Antibacterial Activity of Bryopsis 
pennata and Chaetomorpha antennina against 
Multidrug Resistant Morganella morganii and 
Salmonella species Isolated from Healthy 
Individuals 
 
Folashade Agbaje-Daniels1,2*, Agape Babalola1, Ifeoluwa Akintayo1,  
Adeyemi Adeleye2 and Denzil Beukes3 
 
1Department of Biological Sciences, Crawford University, Igbesa, Ogun State, Nigeria. 
2
Department of Microbiology, University of Lagos, Lagos, Nigeria. 
3
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Western Cape, Bellville, 




This work was carried out in collaboration between all authors. Author FAD designed the study, 
performed the statistical analysis, wrote the protocol, wrote the first draft of the manuscript and 
managed the literature searches. Authors AB and IA managed the analyses of the study. Authors AA 







(1) Krishna Gudikandula, Department of Microbiology, Kakatiya University, Warangal, India.  
Reviewers: 
(1) Essam Hussein Abdelshakour, Al-Azhar University, Egypt. 
(2) Mustapha Umar, Nigerian Institute of Leather and Science Technology, Nigeria. 




Received 2nd August 2017 








The problem of antibiotic resistance is fast becoming a pandemic which has necessitated the need 
for new drugs discovery. This study was carried out to screen two green algal species- Bryopsis 
pennata and Chaetomorpha anteninna for antibacterial activity against multidrug resistant 
pathogenic enteric organisms (Morganella morganii and Salmonella species) obtained from healthy 
individuals. Algal samples were obtained and processed. Crude extraction was carried out with 










dichloromethane/methanol (2:1) while the antibacterial screening was done by agar-well diffusion 
method. Results revealed that M. morganii was 3.37% of the total isolates recovered while 
Salmonella species was 6.74%. Result also showed that C. antennina was active against all the 
strains of Salmonella species with inhibitory zones ranging from 10 mm to 17 mm and the                   
M. morganii with inhibitory zone of 11 mm while B. pennata showed inhibitory activities against only            
S. pullorum and S. enterica subspecies diarizonae with inhibitory zones of 12 mm and 7 mm 
respectively as well as the M. morganii strain with 14 mm. The antibacterial activities observed from 
these green algae showed that Bryopsis pennata and Chaetomorpha antennina from the West 
African coast are promising in the quest for new drugs with potentials against multidrug resistant 
strains of bacteria and therefore should be intensely researched into. 
 
 




Human anatomical sites habour a variety of 
microorganisms both in health and disease state. 
Although many are regarded as commensals but 
could become pathogenic under certain 
conditions [1]. Diseases and disease agents that 
were once controlled by antibiotics are returning 
in new leagues resistant to these therapies [2]. 
Zafar et al. [3] revealed that microbial 
susceptibility to the commonly prescribed 
antibiotics had drastically decreased in the last 
decade. This resistance to antimicrobials has led 
to increased morbidity, mortality and high cost of 
health care [4]. The physical and chemical 
conditions in the marine environment had been 
attributed to the exhibition of a variety of 
molecules with unique structural features by 
almost every class of marine organism [5].  
Reports had shown that an emerging source of 
new bio-actives might result from the many 
recent studies of microbial diversity in the marine 
environment [6]. The marine environment 
harbors bacteria with antagonistic traits and 
marine microorganisms are a potential source of 
novel antimicrobials [7]. Many of the secondary 
metabolites produced by marine organisms are 
halogenated, reflecting the availability of chloride 
and bromide ions in seawater [8]. 
 
Marine macroalgae are considered as an 
excellent source of bioactive compounds which 
has a broad range of biological activities 
including antibacterial [9,10], antifungal [11] 
antiviral [10], anti-tumor [12], antioxidant [13,14], 
and anti-inflammatories [15,16]. The production 
of antimicrobial activities was considered to be 
an indicator of the seaweeds to synthesize 
bioactive secondary metabolites [17,18]. Some 
algal substances have bacteriostatic and 
bactericidal activity, they have been extensively 
studied by several researchers [17,19,20,21]. 
The importance of macroalgae as a supply for 
new bioactive substances has been growing very 
rapidly in recent years according to Smit [22] and 
Mohamed et al. [23] due to their capacity to 
produce metabolites that exhibit various 
biological activities. 
 
2. MATERIALS AND METHODS 
 
2.1 Sample Site 
 
Samples were collected from the paradise and 
Sakumono beaches in Accra, Ghana. 
 
2.1.1 Sample collection 
 
Species of fresh algae were collected by 
detaching them from rock surfaces at low tides.  
Other samples were collected using a knife to 
pull off from rocks at low tides to avoid heavy 
wave action in March 2014 between the hours of 
9.00 am and 1pm. These samples were 
immediately kept under ice in an ice-box and 
transported to the laboratory where they were 
sorted out and thoroughly washed with fresh 
water. These samples were properly identified 
and authenticated by a marine Botanist in the 
University of Ghana. They were kept frozen until 
extraction period.   
 
2.1.2 Crude extraction 
 
The crude extract was obtained by Maceration of 
algal sample for 30 mins at 40°C according to 
Afolayan et al. [24]. A mass of 50 g of the sample 
was macerated in 300 ml of Dichloromethane: 
methanol (2:1) and the temperature was raised 
to about 40°C for 30 mins. After 30 mins, the 
supernatant was filtered and the process 
repeated two more times. The supernatant was 
dried en vacuo using rotary evaporator (Buchi 
200, Germany) at 40°C. Extract concentrate was 
kept frozen until needed. 
Map 1. Map showing the sampling sites
 
2.1.3 Antibacterial screening of extract
 
Fresh cultures of the different species of 
Salmonella species and Morganella morganii
obtained from healthy individuals were obtained 
from the Microbiology laboratory, Crawford 
University, Igbesa, Ogun State. Using the agar 
well diffusion method to enumerate the antibiotic 
susceptibility pattern of the test bacteria. The test 
isolates were screened against the commonly 
prescribed antibiotics. Plates containing 20 ml of 
Mueller-Hinton agar were seeded with cotton 
applicator dipped in bacterial suspension 
standardized with 0.5 McFarland standard. Wells 
were bored with borer of 6 mm in diameter on the 
plates where 0.1 ml i.e. 200 mg/ml of the extract 
were introduced into the wells, and was allowed 
to diffuse for some minutes before incubation at 
37°C for 48 hours. The diameters of inhibition 
were measured. Antibiotic resistance profile was 
obtained by using the disc diffusion method of 




Result shows the sensitivity profile of 
morganii, Salmonella enterica 
diarizonae, Salmonella enterica 
houtenae and Salmonella pullorum.
 
Morganella morganii was resistance to all the 
antibiotics while some of the Salmonella 
were resistance and some sensitive to the 














antibiotics. Table 1 shows the an
resistance profile of test isolates. 
 
The antibacterial screening of Bryopsis pennata
against the isolates revealed that all tested 
isolates were inhibited except a strain of 
Salmonella enterica subspecies diarizonae
Salmonella enterica subspecies houtenae.
zone of inhibition was highest in M. morganii
mm) and lowest in another strain of 
enterica subspecies diarizonae (7
shown below in Table 2. 
 
The result for Chaetomorpha antennina
antimicrobial screening revealed that all test 
isolated were inhibited by the alga with zones of 
inhibition ranging from 10 mm (in 
enterica subspecies houtenae
enterica subspecies diarizonae and 
to 17 mm (Salmonella enterica




The search for new antimicrobial agents has 
been on the rise due to the resistance of some 
pathogenic microorganisms to commonly 
prescribed antimicrobial drugs. High antimicrobial 
resistance had been previously reported 
amongst enteric organisms. The seaweeds are a 
promising source of natural products because 





























Table 1. Antibiotic resistance profile of test isolates 
 
 OFL AUG NIT CPR CAZ CRX GEN CXM 
Salmonella enterica 
subspecies diarizonae 
S R S S R R S R 
Salmonella enterica 
subspecies diarizonae 
S R S R R R S R 
Salmonella pullorum S R S S R R R R 
Salmonella enterica 
subspecies houtenae 
S R R S R R S R 
Morganella morganii R R R R R R R R 
Key: OFL- Ofloxacin, AUG- Augumetin, NIT- Nitrofurantoin, CPR-Ciprofloxacin, CAZ-Ceftazidime, CRX- 
Cefuroxime, GEN- Gentamicin, CXM- Ceftriaxone, R- Resistance (below 10 mm), S- Sensitive (16 mm and 
above) 
 
Table 2. The antibacterial screening of 
Bryopsis pennata against Salmonella species 
and Morganella morganii at 200 µg/ml 
 












Morganella morganii 14.00 
 
Table 3. The antibacterial screening of 
Chaetomorpha antennina against Salmonella 
species and Morganella morganii at 200 µg/  
 












Morganella morganii 11.00 
 
From this study, dichloromethane extract of 
Chaetomorpha antennina was active against 
different species of Salmonella (Salmonella 
pullorum, Salmonella enteric subspecies 
diarizonae, and Salmonella enetrica subspecies 
houtenae) which gave a zone of inhibition 
ranging from 10.00 mm-17.00 mm, previous 
reports revealed that Dichloromethane (DCM) 
and methanolic crude extracts of  some algae 
had biological activities [24], and it has also been 
reported from phytochemical analysis of 
Chaetomorpha antennina crude extract that it 
contains glycosides, tannin, terpenoids and 
phenolics [28]. The inhibitory activities observed 
in this study would be credited to the presence of 
these biologically active metabolites. Terpenoids 
and phenolics had been previously reported as 
good antimicrobials [29] so also are glycosides 
and tannins [30].  
 
This study revealed the inhibitory activity of                
C. antennina against M. morganii. The inhibitory 
activity of a green alga (Caulerpa cupressoides) 
against M. morganii had been previously 
reported [31]. The virulence of M. morganii could 
be attributed to the possession of resistance 
plasmid which had previously been reported by 
Cunha [32]. This agent has been reportedly 
implicated in nosocomial infections, sepsis and 
some other infections [33]. The involvement of 
this bacterium in such infections poses a health 
threat because of its multiple resistance to 
antimicrobial drugs as previously been reported 
and observed in this study. Also, C. antennina 
extract showed inhibitory activities against 
Salmonella pullorum, Salmonella enterica 
subspecies diarizonae, Salmonella enterica 
subspecies houtenae and Morganella morganii. 
Salmonella pullorum infection affects birds and 
poultry products and this could be easily 
transmitted to man through consumption of such 
food. 
 
The antibacterial screening of B. pennata against 
the species of Morganella and Salmonella in this 
study revealed the inhibitory activities of this alga 
against the bacteria. The B. pennata crude 
extract was active against M. morganii and some 
of the strains of Salmonella species tested. 
Previous reports revealed the isolation of fatty 
acid and sterols [34] as well as depsipeptides 











Fatty acids and sterols have previously been 
reported as good antimicrobial compounds. 
Depsipeptides’ pharmacological activities had 
also been previously documented [36].                        
The inhibitory activities observed against                   
these bacterial species may thus be attributed to 
these compounds. The crude extracts of the 
algae in this study inhibited multiple drug 
resistant enteric bacteria as observed in this 
study. This informs that if properly researched 
into, pure compounds from these algae could be 
really promising in the quest for new 





These results provide good evidence that 
antimicrobial chemical defenses are wide spread 
among marine algae, they have shown that algae 
are promising organisms to furnish novel 
biochemically active compounds in 
pharmaceutical industry. Moreover, the activity 
profile of the algal extract suggests that 
antimicrobial secondary metabolites can be 
pathogen-selective or broad-spectrum effective. 
This result also buttresses the fact that marine 
algae from West African coasts if well explored 
may bring great therapeutic intervention against 
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